ProCE Banner Activity


Mitigating Tardive Dyskinesia in Aging Patients With Mood Disorders


On-demand webcast recording of the tardive dyskinesia presentation by Greg W. Mattingly, MD, held at the 10th Annual Mood Disorders Summit.

Psychologists: 1.00 APA CE Credit

Social Workers: 1.00 ASWB ACE CE Credit

Nurses: 1.00 Nursing contact hour, including 1.00 hour of pharmacotherapy credit

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

Pharmacists: 1.00 contact hour (0.1 CEUs)

Released: October 12, 2023

Expiration: October 11, 2024



Joseph F. Goldberg

Joseph F. Goldberg, MD

Clinical Professor of Psychiatry 
Icahn School of Medicine at Mount Sinai 
American Society of Clinical Psychopharmacology 
New York, New York

Greg W. Mattingly

Greg W. Mattingly, MD

Associate Clinical Professor
Washington University
Midwest Research Group
President Elect
American Professional Society for ADHD and Related Disorders
St. Louis, Missouri

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by an educational grant from Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc.

Target Audience

This educational program is intended for psychiatrists, nurse practitioners, physician associates/physician assistants, general and family practice physicians, gerontologists, pharmacists, psychologists, social workers, and other HCPs who treat patients with tardive dyskinesia who may benefit from this education.

Program Learning Goal

The goal of this program is to provide the latest information spanning a variety of topics about tardive dyskinesia, including screening, diagnosis, and treatment, with considerations for special populations and tardive dyskinesia in long-term care and aging populations.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify relative prevalence and risk of TD across various disease states 

  • Interpret screening tools for the identification of TD, including patient and caregiver reports 

  • Construct an individualized treatment plan for patients with TD with age-related or other special characteristics 


Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Joseph F. Goldberg, MD

Clinical Professor of Psychiatry 
Icahn School of Medicine at Mount Sinai 
American Society of Clinical Psychopharmacology 
New York, New York

Joseph F. Goldberg, MD: consultant/advisor/speaker: AbbVie, Alkermes, Axsome, BioXcel, Genomind, Intracellular Therapies, Neurelis, Neuroma, Otsuka, Sunovion, Supernus.

Greg W. Mattingly, MD

Associate Clinical Professor
Washington University
Midwest Research Group
President Elect
American Professional Society for ADHD and Related Disorders
St. Louis, Missouri

Greg W. Mattingly, MD: consultant/advisor/speaker: AbbVie, Alkermes, Axsome, Biogen, Corium, Eisai, Ironshore, Intracellular, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Redax, Roche, Sage, Sirona, Sunovion, Supernus, Takeda, Teva, Trispharma; researcher: AbbVie, Alkermes, Akilli, Axsome, Boehringer Ingelheim, Emalex, Idorsida, Janssen, Karuna, Lumos Labs, Medgenics, Neurocrine, NLS-1 Pharma AG, Otsuka, Redax, Relmada, Roche, Sage, Sirtsei, Sunovion, Supernus, Takeda, Teva.

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose, except Gabrielle Giacona and Michael Asbach, DMSc, PA-C, Psych-CAQ, as noted below.

Gabrielle Giacona: stock/stock options: AstraZeneca, Moderna.

Michael Asbach, DMSc, PA-C, Psych-CAQconsultant/advisor/speaker: AbbVie, Avanir, Biogen, Janssen, Karuna, Neurocrine, Otsuka.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1 hour. To successfully complete this activity and receive credit, learners must follow these steps during the period from October 12, 2023, through October 11, 2024:

  1. Login or Sign Up for an account by clicking at the top of this page
  2. Read the target audience, learning objectives, and faculty disclosures
  3. View and study the content in its entirety
  4. Submit answers to the post-test questions and evaluation questions online

You must receive a test score of 65 or better and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.


This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


Joint Accreditation Statement
Joint AccreditationIn support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 


Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1 contact hour including 1.0 hour of pharmacotherapy credit.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number -  JA4008176-0000-23-254-H01-P 
Type of Activity: Application

Upon successfully completing the post-test with a score of 65 and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate Continuing Medical Education
Joint AccreditationClinical Care Options has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credit. Approval is valid until October 11, 2024. PAs should only claim credit commensurate with the extent of their participation.


Psychologist Continuing Education

Continuing education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.

This activity offers 1 continuing education credits for psychologists. 

Social Work Continuing Education

As a Jointly Accredited Organization, Clinical Care Options, LLC is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1 clinical continuing education credits.